TechNavio's analysts forecast the Global HPV Testing market to grow at a CAGR of 19.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in risk of the number of people prone to HPV. The Global HPV Testing market has also been witnessing the increase in mergers & acquisitions. However, the limited number of health clinics could pose a challenge to the growth of this market. TechNavio's report, the Global HPV Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global HPV Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space are bioMérieux SA., Hologic Inc., Roche Diagnostics Ltd., and Qiagen N.V. Other vendors mentioned in the report are Abbott Molecular Inc., Arbor Vita Corp., Becton, Dickinson and Co., IncellDx Inc., Quest Diagnostics Inc., Trovagene Inc., and Ventana Medical Systems Inc. Key questions answered in this report: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.